Mayo Clinic Vaccine Research Group, Mayo Clinic, Guggenheim 611C, 200 1st Street S.W., Rochester, MN, 55905, USA.
Hum Genet. 2014 Sep;133(9):1083-92. doi: 10.1007/s00439-014-1449-x. Epub 2014 Jun 1.
We previously reported HLA allelic associations with vaccinia virus (VACV)-induced adaptive immune responses in a cohort of healthy individuals (n = 1,071 subjects) after a single dose of the licensed smallpox (Dryvax) vaccine. This study demonstrated that specific HLA alleles were significantly associated with VACV-induced neutralizing antibody (NA) titers (HLA-B*13:02, *38:02, *44:03, 48:01, and HLA-DQB103:02, 06:04) and cytokine (HLA-DRB101:03, 03:01, 10:01, 13:01, 15:01) immune responses. We undertook an independent study of 1,053 healthy individuals and examined associations between HLA alleles and measures of adaptive immunity after a single dose of Dryvax-derived ACAM2000 vaccine to evaluate previously discovered HLA allelic associations from the Dryvax study and determine if these associations are replicated with ACAM2000. Females had significantly higher NA titers than male subjects in both study cohorts [median ID50 discovery cohort 159 (93, 256) vs. 125 (75, 186), p < 0.001; replication cohort 144 (82, 204) vs. 110 (61, 189), p = 0.024]. The association between the DQB103:02 allele (median ID50 discovery cohort 152, p = 0.015; replication cohort 134, p = 0.010) and higher NA titers was replicated. Two HLA associations of comparable magnitudes were consistently found between DRB104:03 and DRB108:01 alleles and IFN-γ ELISPOT responses. The association between the DRB115:01 allele with IFN-γ secretion was also replicated (median pg/mL discovery cohort 182, p = 0.052; replication cohort 203, p = 0.014). Our results suggest that smallpox vaccine-induced adaptive immune responses are significantly influenced by HLA gene polymorphisms. These data provide information for functional studies and design of novel candidate smallpox vaccines.
我们之前报道了在单次接种许可的天花(Dryvax)疫苗后,1071 名健康个体的队列中,HLA 等位基因与痘苗病毒(VACV)诱导的适应性免疫反应之间的关联。这项研究表明,特定的 HLA 等位基因与 VACV 诱导的中和抗体(NA)滴度(HLA-B*13:02、*38:02、*44:03、48:01 和 HLA-DQB103:02、06:04)和细胞因子(HLA-DRB101:03、03:01、10:01、13:01、15:01)免疫反应显著相关。我们对 1053 名健康个体进行了一项独立研究,并在单次接种 Dryvax 衍生的 ACAM2000 疫苗后,检查了 HLA 等位基因与适应性免疫测量值之间的关联,以评估 Dryvax 研究中发现的 HLA 等位基因关联,并确定这些关联是否在 ACAM2000 中得到复制。在两个研究队列中,女性的 NA 滴度均显著高于男性[中位 ID50 发现队列 159(93,256)比 125(75,186),p<0.001;复制队列 144(82,204)比 110(61,189),p=0.024]。DQB103:02 等位基因(中位 ID50 发现队列 152,p=0.015;复制队列 134,p=0.010)与较高的 NA 滴度之间的关联得到了复制。在 DRB104:03 和 DRB108:01 等位基因与 IFN-γ ELISPOT 反应之间,始终发现了两个具有相当大小的 HLA 关联。DRB115:01 等位基因与 IFN-γ 分泌的关联也得到了复制(中位 pg/mL 发现队列 182,p=0.052;复制队列 203,p=0.014)。我们的结果表明,天花疫苗诱导的适应性免疫反应受到 HLA 基因多态性的显著影响。这些数据为功能研究和新型候选天花疫苗的设计提供了信息。